Histone deacetylase inhibitor 2-hexyl-4-pentynoic acid enhances hydroxyurea therapeutic effect in triple-negative breast cancer cells

Ding, CX; Su, BY; Li, QL; Ding, WW; Liu, GC; Cai, ZC; Zhang, FM; Lim, D; Feng, ZH

Feng, ZH (通讯作者),Shandong Univ, Sch Publ Hlth, Dept Occupat Hlth & Occupat Med, Jinan 250012, Shandong, Peoples R China.

MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2022; 873 ():

Abstract

Triple-negative breast cancer (TNBC) treatment has only limited effect, and it causes a significant number of deaths. Histone deacetylase inhibitors (......

Full Text Link